A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
|
|
- Marylou Summers
- 6 years ago
- Views:
Transcription
1 SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument refers t yu r yur child. WHAT IS THIS STUDY ABOUT? This study is a clinical trial (a type f research study using human patients). Clinical trials include nly patients wh chse t take part. Please take yur time t make yur decisin. Discuss yur decisin with yur friends and family. Yu are being asked t participate in this study because yu have been diagnsed with neurblastma, a type f slid cancer that usually affects children. Yur cancer has either relapsed r yu have persistent tumr after having gtten standard treatment. Standard treatment may have included chemtherapy, surgery, radiatin therapy and/r high-dse chemtherapy with a stem cell transplant. WHY IS THIS STUDY BEING DONE? The purpses f this study are: T find the highest dse f CEP-701 that can be given twice a day Mnday thrugh Friday withut causing severe side effects. T find ut the side effects seen with giving CEP-701 n this schedule at different dse levels. T measure bld levels f CEP-701 during treatment and t see if the drug at these levels can kill neurblastma cells in a test tube r in yur bne marrw. T determine if yur tumr gets smaller after treatment with CEP-701. The research is being dne because: Currently there is n knwn effective treatment fr yur type f cancer. CEP-701 is an anticancer drug that wrks differently than standard chemtherapy medicines. It blcks signals that helps the neurblastma cancer cells t live and grw. These signals are taken int the cell thrugh prteins called Trks fund n surface f mst neurblastma cancer cell. CEP-701 blcks these signals in lab studies. CEP-701 has been given safely t adults with different cancers. It may have helped sme leukemia patients, but there has been n shrinkage f adult slid cancers studied s far. The majr side effects seen have been nausea, vmiting, diarrhea, cnstipatin, lss f appetite and feeling weak. This is first study f CEP-701 in children. HOW MANY PEOPLE WILL TAKE PART IN THIS STUDY? Between peple will take part in this study.
2 WHAT WILL HAPPEN TO ME ON THIS STUDY AND WHAT IS INVOLVED? If yu agree t be n this study, we will ask yu t d the fllwing things. CEP-701 is taken by muth twice a day with r after breakfast and dinner fr 5 days (Mnday thrugh Friday) fllwed by 2 days f rest (Saturday and Sunday) when n drug is taken. This is repeated 4 times fr a ttal f 28 days fr ne curse f treatment. The drug cmes as a liquid and shuld be mixed with juice. We will teach yu hw t give the drug. Dse escalatin f CEP-701 Yu will nly receive ne dse f CEP-701. Fr the whle study, we will analyze each dse in 3-6 patients at a time. The starting dse fr the first grup f patients is abut 25% lwer than what is currently being given t adult patients withut bad side effects. The dse f CEP-701 will be increased ( dse escalatin ) in grups f 3-6 patients until side effects are seen. At this pint investigatrs will have fund the highest dse f CEP-701 that can be given twice a day Mnday - Friday withut bad side effects. We will tell yu what dse yu will receive and answer yur questins abut dse escalatin. Yu will have a series f standard medical tests befre, during and fllwing treatment with CEP Researchers will use these tests t measure the effectiveness f the treatment and what it is ding t yur bdy. MEDICAL TESTS BEFORE AND DURING TREATMENT -Physical exam -Bne marrw tests # -Bld tests -Varius scans* -Pregnancy test -Test f heart functin (befre starting treatment nly) -Urine tests # Bne marrw tests are dne by inserting a needle int the hip bne t remve the marrw which is inside the bne. * VARIOUS SCANS THAT ARE DONE FOR DIAGNOSIS AND CHECKING THE RESPONSE OF THE TUMOR TO TREATMENT. THESE MAY INCLUDE CT AND /OR MRI SCANS AND MIBG SCANS. WE WILL RECOMMEND SCANS SPECIFIC FOR YOUR CASE AND WE WILL ANSWER YOUR QUESTIONS ABOUT THESE SCANS. The chart at the end f this frm tells yu when these tests need t be dne. Medical Tests Fllwing Treatment -Physical exam -Bld tests -Bne marrw tests -Urine tests -Varius scans -Test f heart functin In additin t the rutine studies listed abve that are required t mnitr yur prgress during treatment, we wuld like t perfrm additinal studies such as pharmackinetic (bld level) studies and tumr bilgy studies while yu are enrlled n this prtcl. Each f these special studies is described in the sectins belw. Althugh these studies are very imprtant t imprving ur understanding f this new drug, the results f these studies will nt directly influence yur treatment. Yu may chse nt t participate in the pharmackinetic and bilgy studies and will still be eligible t receive the experimental treatment. The results f these studies will nt affect yur treatment while enrlled n this study and the study results will nt be tld t
3 yu r yur dctr and will nt becme part f yur medical recrd. The investigatrs will use the samples t study hw yur bdy uses the medicatin and if the medicatin has any effect n the tumr cells. There are checkbxes n the next t last page f this cnsent frm t mark whether yu are willing t participate in these vluntary studies. Determining Bld Levels f CEP-701 (called Pharmackinetics) Part f the research gal fr this study is t lk at the level f CEP-701 in the bld. A little mre than half a teaspn f bld (3ml) will be drawn frm a vein (by intravenus r central line) at 12 different times n first day yu start treatment with CEP-701. On this day yu will nly take the mrning dse f drug. The first sample is taken befre taking the dse f CEP-701, then several times fr the first 8 hurs after yu take the drug, and then 24 hurs after taking the drug. Tw mre samples will be drawn n day 5 and 26 befre yu take the mrning dse f CEP-701. This can all be dne in the utpatient clinic. This part f the study is vluntary. Deciding nt t take part in this part f the study will nt affect yur verall care r yur ability t get CEP-701 as part f this clinical trial. Bilgy Studies dne fr Research Purpses Anther research gal fr this study is t find ut if CEP-701 in yur bld can kill neurblastma cells. This infrmatin will help researchers t understand if CEP-701 still might be wrking even if yur tumr des nt shrink. Bld Study. This testing requires taking 2 extra teaspns f bld 3 times n days 1, 5 and 26 f treatment. The results f these tests will be cnfidential and will nt be made available t yu r yur treating physician as they are experimental and will nt be used t determine therapy. This part f the study invlving bld tests n days 1, 5, and 26 is vluntary. Deciding nt t take part in this part f the study will nt affect yur verall care r yur ability t get CEP-701 as part f this clinical trial. HOW LONG WILL I BE ON THIS STUDY? Yu can cntinue t get treatment every 28 days fr as lng as yur neurblastma respnse t the treatment r yu d nt have bad side effects frm taking CEP-701. After yu stp treatment with CEP-701, yu will cntinue t have tests and scans dne t measure hw much tumr is left. Yur dctr will tell yu hw ften these tests will be dne. Researchers will cntinue t cllect infrmatin abut yu fr a lifetime. Infrmatin will be cllected abut whether yu are still alive, whether yur tumr has grwn back and at what sites in the bdy; whether yu have develped any side effects frm the treatment r any additinal cancer. This infrmatin may be gtten frm yur nclgist r family dctr at regular intervals. Yu can remve yurself frm this study at any time.
4 WHAT ARE THE RISKS OF THE STUDY? The majr risks are related t the experimental drug CEP-701. Side effects seen FREQUENTLY in adult patients: Nausea Diarrhea Lss f appetite and nt feeling like eating Overall feelings f bdy weakness Cnstipatin Vmiting Side effects seen RARELY in adult patients: Feelings f indigestin, stmach upset Lw bld pressure Bleeding frm the gut Heart failure Side effects seen FREQUENTLY in children: Nausea Diarrhea Lss f appetite and nt feeling like eating Cnstipatin Vmiting Liver irritatin/increased liver functin tests. Other drugs may be given t make side effects less serius and mre cmfrtable. Many side effects g away shrtly after the treatment is stpped, but in sme cases, side effects may be lng lasting r permanent. Sme side effects may be life threatening and it is pssible that death culd ccur as a rare side effect fllwing treatment with CEP-701. Patients are watched carefully and treatment will be stpped if bad side effects develp. Because this drug has never been given t children befre, there may be risks we d nt knw abut. Because this drug can affect an unbrn baby, patients f child-bearing age shuld nt becme pregnant r father a baby while n this study. Ask abut cunseling and mre infrmatin abut preventing pregnancy. The risks frm having yur bld taken are minimal but can result in a infectin r a bld clt. Experienced dctrs r nurses will perfrm these bld draws t minimize this risk. Bne marrw tests als can lead t infectin, and they ften require that yu get sedatin (sleep) medicines. Bne marrw tests may cause pain during the prcedure r bleeding at the site n yur hip where the test was dne. These have risks that will be discusses with yu. Yu will sign separate cnsent fr any prcedure that needs sedatin. WILL I BENEFIT FROM THIS STUDY? There may r may nt be direct medical benefit t yu. The infrmatin learned frm this study may r may nt benefit ther children r yung peple with slid cancers in the future.
5 ARE THERE OTHER TREATMENT OPTIONS? Yes there are ther ptins fr treatment. Instead f being in this study, yu have these ptins: Treatment with chemtherapy medicines. Treatment with ther experimental agents that may be available. N therapy at this time with care t help yu feel mre cmfrtable. Please talk abut these ptins with yur dctr. WILL MY RECORDS BE CONFIDENTIAL? Yu may read yur recrd. The recrds are available t thse peple caring fr yu at this hspital. Hwever, all effrts will be made t keep yur infrmatin cnfidential. Unfrtunately, we cannt guarantee abslute cnfidentiality. Infrmatin abut yu may be shared if required by law. Organizatins that may lk at and/r cpy yur (yur child's) research recrds fr quality assurance and data analysis include such grups as: New Appraches T Neurblastma Therapy (NANT) Cnsrtium at Childrens Hspital Ls Angeles in Ls Angeles, CA. The NANT Cnsrtium identifies yu (yur child) by a number. Independent auditr evaluating quality assurance fr the NANT Cnsrtium The Federal Gvernment Natinal Cancer Institute (NCI) and the Fd and Drug Administratin (FDA) may examine recrds f patients participating in this study. Cephaln Inc., the cmpany supplying CEP-701 fr this study. WILL I HAVE TO PAY FOR THIS TREATMENT? Cephaln, Inc. will prvide CEP-701 free f charge fr this study. If during the study CEP-701 becmes cmmercially available, yu may have t pay fr the amunt f drug needed t cmplete the study. Taking part in this study may lead t added csts that may be cvered by yur insurance cmpany. Please ask abut any expected added csts r insurance prblems. In case f illness r injury resulting frm this study, emergency medical treatment is available but will be prvided at the usual charge. N funds have been set aside t cmpensate yu in the event f an injury. Yu and/r yur insurance cmpany will be charged fr cntinuing medical care r hspitalizatin. Yu will receive n payment fr taking part in this study. Yu may have t pay fr ther things during this study, such as but nt limited t, yur time, the cst f fd yu buy while yu are being treated at the hspital, car fare, parking, and baby sitter fees.
6 WHAT ARE MY (MY CHILD S) RIGHTS AS A STUDY PARTICIPANT? Taking part in this study is vluntary. Yu may chse nt t take part in this study. If yu participate, yu may remve yurself frm the study at any time. If yu remve yurself frm the study, we will still take care f yu. We will explain what stpping the treatment may d and we will ffer ther treatments if they are available. Yu will nt be penalized r lse any regular benefits. Yu als have the right t knw abut new infrmatin that may affect yur health, welfare, r willingness t stay in the study. We will give yu this infrmatin. WHOM DO I CALL IF I HAVE QUESTIONS OR PROBLEMS? Fr questins abut the study r an injury related t the research, please call NAME at TELEPHONE NUMBER Fr questins abut yur (yur child's) rights as a study participant, please call NAME OF INSTITUTIONAL REVIEW BOARD REPRESENTATIVE # NAME at TELEPHONE NUMBER # The Institutinal Review Bard is a grup f peple wh review the research study t prtect yur rights. WHERE CAN I GET MORE INFORMATION? Yu may call the NCI s Cancer Infrmatin Service at CANCER ( ) r TTY: Visit the NCI s Web sites Cancer Trials: cmprehensive clinical trials infrmatin Cancer Net : accurate cancer infrmatin including PDQ -Yu will get a cpy f this cnsent frm. -Yu may als ask fr a cpy f the prtcl (full study plan).
7 Cnsent fr Extra Studies fr Research Bld Levels f CEP-701 (Pharmackinetics) #1 Circle YES, if yu agree t let researchers take a little mre than half a teaspn f bld (3ml) 12 times n the first day f treatment with CEP-701 and 1 mre sample each n day 5 and day 26 f treatment (ttal 14 samples) t lk at the level f CEP-701 in the bld. These are extra bld draws. The results f these tests will be cnfidential and nt made available t yu r yur treating physician. Circle NO, if yu d nt want researchers t take 14 extra bld samples t lk CEP-701 levels in the bld. #1 YES NO Signature Participant: : Bld fr Tumr Bilgy Studies #2 Circle YES if yu agree t let researchers take an extra 2 teaspns f bld 3 times n day 1, 5 and 26 f curse ne t lk at activity f Trk B in the bld. This testing wuld require 3 extra bld draws n days 1, 5 and 26. The results f these tests will be cnfidential and nt made available t yu r yur treating physician. Circle NO if yu d nt want researchers t take an extra tw teaspns f bld 3 times fr bld studies abut Trk B activity. #2: YES NO Signature Participant: :
8 STATEMENT OF CONSENT I have already read the infrmatin in this infrmed cnsent dcument. I have read all the attachments that were included with this infrmed cnsent dcument. I have asked all f my questins and I have gtten answers. I agree t enrll myself (my child) in this study. Patient Name Signature f Parent r Guardian / / Signature f Parent r Guardian / / Signature f Patient (If > 7 years ld) / / Signature f Physician r Respnsible Investigatr Signature f Witness / / / / Signature f Translatr (If applicable) / /
9 STUDY Cnsent Addendum: Tests that will be dne n this study. Befre Study During Curse 1 End f Curse 1 During Curse 2 Physical Exam X X X X X Bld tests X Weekly X Every ther week End f Curse 2, 4 and Off Prtcl Rx Pregnancy test X - X - X Urine test X Heart test (ECHO) X - - X (ff Prt. Rx) Tumr imaging (CT/MRI & X - X - X MIBG scan) Bilateral bne marrw aspirate/bipsy Bne marrw fr immuncytlgy X - X (nly if + at start f study) X - X (nly if + at start f study) X - X (nly if + at start f study) - X (nly if + at start f study) Urine test (VMA/HVA) X - X - X CEP-701 bld levels - X (nly if cnsent given) Bld bilgy studies - Day 5 (nly if cnsent given) - - -
You may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationMy Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)
My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made
More informationFOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES
Appendix h STUDY NUMBER: COST OF UNSAFE ABORTION FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES T be administered abut 2-3 weeks after leaving the health facility 1. IDENTIFICATION 101. Patient identificatin
More informationAdvantage EAP Employee Assistance Program
Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationMEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP
MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets
More informationHealth for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y
Health fr Life Chirpractic At Clverdale Mall Unit #143-250 The East Mall Etbicke, ON, M9B 3Y8 416-232-1822 416-232-0060 Child and Adlescent Health Questinnaire Name:_ Birth date: Address:_ Telephne: Medical
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationMEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP
MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride
More informationDental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.
Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationUniversity College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service
University Cllege Hspital Pump schl Starting n an insulin pump Children and Yung Peple s Diabetes Service 2 If yu wuld like this dcument in anther language r frmat, r require the services f an interpreter,
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationALCAT FREQUENTLY ASKED QUESTIONS
1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationPATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:
PATIENT INFORMATION Rsuvastatin Calcium (re-soo-va-stat-in KAL-see-um) Tablets Read this Patient Infrmatin carefully befre yu start taking rsuvastatin calcium tablets and each time yu get a refill. If
More informationVaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE
Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationANXIETY SYMPTOMS INTERVENTION SESSION HANDOUTS. Introduction to Fighting Fear by Facing Fear. Making a Fears and Worries List
SESSION ANXIETY SYMPTOMS INTERVENTION 5 SESSION HANDOUTS Handut 5.1: Handut 5.2: Handut 5.3: Handut 5.4: Handut 5.5: Handut 5.6: When Yu Face Yur Fears STOP! Intrductin t Fighting Fear by Facing Fear The
More informationMEDICATION GUIDE. (fingolimod) capsules
MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the
More informationCONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS
CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,
More informationBefore Your Visit: Mohs Skin Cancer Surgery
Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with
More informationMedication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)
Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause
More informationHead and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.
DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that
More informationName of procedure: Removal of submandibular salivary gland
Oral facial surgery Surgical prcedure infrmatin leaflet Name f prcedure: Remval f submandibular salivary gland This leaflet explains sme f the benefits, risks and alternatives t the peratin. We want yu
More informationMEDICATION GUIDE. (canagliflozin) Tablets
MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can
More informationUnderstanding Blood Counts
Understanding Bld Cunts PMH This pamphlet is fr patients at Princess Margaret Hspital. It will help yu t read and understand the bld cunt infrmatin yu get frm the bld lab. Patient Educatin Imprving Health
More informationPART III: CONSUMER INFORMATION
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically
More informationWHAT IS HEAD AND NECK CANCER FACT SHEET
WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationMEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?
MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidmide) capsules What is the mst imprtant infrmatin I shuld knw abut REVLIMID? Befre yu begin taking REVLIMID, yu must read and agree t all f the instructins
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationPatrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip
Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery
More informationVaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE
Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationAssessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams
Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.
More informationPILI Lifestyle Program Facilitator s Guide
Update: Octber 13, 2006 Page 1 f 12 PILI Lifestyle Prgram Facilitatr s Guide Sessin 3: Lwering Fat & Getting a Mve n Questin/Tpic Script Reminder/Activity Page Welcme back! Alha and welcme t the third
More informationMEDICATION GUIDE. (Interferon alfa-2b)
MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationGUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH
GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting
More informationSuccess Criteria: Extend your thinking:
Discussin Directr Yur jb is t invlve thers in cnversatin abut the text by getting them t think and talk abut the BIG IDEAS in the chapter/ sectin they have just read. Cmpse 5 questins that yu want t discuss
More information454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place
MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and
More informationCRANIOFACIAL RESECTION
CRANIOFACIAL RESECTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins
More information/0515 Medication Guide Aripiprazole Tablets
8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This
More informationPHARYNGO-OESOPHAGECTOMY
PHARYNGO-OESOPHAGECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins
More informationMEDICATION GUIDE. Reference ID:
MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.
More informationThese are medical emergencies that can cause death. If possible, remove OTFC from the mouth.
MEDICATION GUIDE Oral Transmucsal Fentanyl Citrate (OTFC) CII (fentanyl citrate) ral transmucsal lzenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg IMPORTANT: D nt use Oral Transmucsal Fentanyl
More informationFTD RESEARCH: The Value of Studies and Opportunities for Involvement
FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationDr. Tozzi s and Dr. Roehrig s Patient Guide to Total Hip Replacement
Dr. Tzzi s and Dr. Rehrig s Patient Guide t Ttal Hip Replacement This guide is meant t help yu better understand yur upcming hip surgery. It is generalized infrmatin, and individual patients have unique,
More informationGetting Started. Learning Guide. with Continuous Glucose Monitoring for the MiniMed 530G with Enlite. CGM Foundations
Getting Started with Cntinuus Glucse Mnitring fr the MiniMed 530G with Enlite Learning Guide CGM Fundatins Cntinuus Glucse Mnitring Learning Guide MiniMed 530G with Enlite - Cntinuus Glucse Mnitring Settings
More informationAdult Preventive Care Guidelines
Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether
More informationScreening Questions to Ask Patients
Screening Questins t Ask Patients 1. Have yu ever had TB (Tuberculsis)? Yes N 2. Have yu been living with anyne in the past tw years that has been diagnsed with TB? Yes N 3. Have yu ever had a Persistent
More informationI am having a Rotator Cuff Repair
I am having a Rtatr Cuff Repair A rtatr cuff repair is surgery t repair a trn tendn in the shulder. The rtatr cuff is a grup f muscles and tendns that frm a cuff ver the shulder jint. The muscles and tendns
More informationA pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.
NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting
More informationPILI Lifestyle Program Facilitator s Guide
PILI Lifestyle Prgram Facilitatr s Guide Sessin 5 Tip the Calrie Balance / Healthy Eating n a Budget" Questin/Tpic Script Reminder/Activity Page Welcme! Alha and welcme back t the fifth lessn f the PILI
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationMEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets
MEDICATION GUIDE XARELTO (zah-rel-te) (rivarxaban) tablets Read this Medicatin Guide befre yu start taking XARELTO and each time yu get a refill. There may be new infrmatin. This Medicatin Guide des nt
More informationMEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII)
MEDICATION GUIDE SUBOXONE (Sub OX wn) (buprenrphine and nalxne) Sublingual Film fr Sublingual r Buccal Administratin (CIII) IMPORTANT: Keep SUBOXONE sublingual film in a secure place away frm children.
More informationRoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation
RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationPILI Ohana Facilitator s Guide
Previus Versin: September 10, 2007 Updated Versin: Octber 2, 2007 PILI Ohana Facilitatr s Guide Lessn 5: Managing and Reducing Negative Thughts and Emtins. Questin/Tpic Script Reminder/Activity Welcming
More informationAnnual Principal Investigator Worksheet About Local Context
Cmpleting the NCI CIRB Annual Principal Investigatr Wrksheet Abut Lcal Cntext and the Study-Specific Wrksheet Abut Lcal Cntext at the University f Iwa All investigatrs cnducting research with the Natinal
More informationAnterior Total Hip Arthroplasty Patient Guide & Common Questions
Intrductin: Anterir Ttal Hip Arthrplasty Patient Guide & Cmmn Questins This handut is a general guide t cmmn indicatins fr anterir ttal hip arthrplasty, what t expect when underging the prcedure, risks,
More informationFad diets Ask the Dietitian Michele Lucas RD CDE
Fad diets Ask the Dietitian Michele Lucas RD CDE WHAT YOU SHOULD KNOW: Weighing t much is nt gd fr yur health. Being verweight increases yur risk f health prblems, like heart prblems, high bld pressure,
More informationIf you have any doubts or queries about your medication, please contact your doctor or pharmacist.
Bayer plc Bayer Huse Strawberry Hill Newbury Berkshire RG14 1JA United Kingdm Telephne: +44 (0)1635 563 000 Facsimile: +44 (0)1635 563 393 Cmpany Web Site: http://www.bayer.c.uk Due t regulatry changes,
More informationImmunisation and Disease Prevention Policy
Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries
More informationCareer Confidence. by Kevin Gaw
Career Cnfidence by Kevin Gaw In additin t the requisite skills, experiences, and rganizatinal match being sught fr a psitin fr which a candidate is applying, mst emplyers screen fr what I call career
More informationBritish Sign Language (BSL) Plan October 2018 Scottish Charity Regulator
British Sign Language (BSL) Plan 2018-2024 Octber 2018 Scttish Charity Regulatr Cntents Sectin 1: Intrductin and cntext 1.1 Intrductin 1.2 Our wrk and what we d Sectin 2: Our BSL Plan 2.1 Scttish Public
More informationAccess to Heme Treatment in Canada - Survey 2018
Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,
More informationThe principles of evidence-based medicine
The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t
More informationUnderstanding and Recognizing Anxiety
Understanding and Recgnizing Anxiety Mst peple d nt recgnize their anxiety fr what it is, and instead think there is smething mre serius ging n. Myth: Reading, thinking, and learning abut anxiety will
More informationDIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY
YOU AND YOUR BODY DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY kk WHY IS THIS LEAFLET FOR YOU? Pancreatic excrine insufficiency (PEI) is imprtant t understand in diabetes care due t the changing functins
More informationUpper Endoscopy (EGD) Prep Guide
Upper Endscpy (EGD) Prep Guide Yu have been scheduled fr an Upper Endscpy (EGD). Plan ahead t help reduce yur stress. Use these step-by-step instructins fr a successful prcedure s that yur dctr can clearly
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationAdvance Care Planning Collaboration 101
Advance Care Planning Cllabratin 101 Stephanie VanSlyke, RN ACP Facilitatr Ethics Cnsultant Michigan Hme Care & Hspice Assciatin Overview Defining the prcess f Advance Care Planning (ACP) Why is ACP imprtant?
More informationGlaucoma Interviews: Due Tuesday, May 22 nd
Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationCONSUMER MEDICINE INFORMATION
CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers sme cmmn questins abut CEFTRIAXONE lcp. It des nt cntain all the available infrmatin. It des nt take the place f talking t yur
More informationPatrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction
Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery
More informationINSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg
INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injectin, fr Subcutaneus Use Single-Dse Prefilled Syringe 150 mg Read this Instructins fr Use befre yu start using ZINBRYTA and each time yu get
More informationModule 6: Goal Setting
Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals
More informationUnderstanding Your Total-Cholesterol-to-HDL Ratio
Understanding Yur Ttal-Chlesterl-t-HDL Rati Yur ttal-chlesterl-t-hdl rati is measured during a bld test called a lipid prfile. This wrksheet will help yu learn mre abut this rati. It will als help yu:
More informationLee County Florida Income Guideline Chart
NEIGHBORHOOD STABILIZATION PROGRAM OF LEE COUNTY BUYER-RELATED QUESTIONS 1. Why is NSP beneficial t yur buyers? Three key advantages make the NSP Prgram especially attractive t eligible buyers: 1) Investrs
More information2019 Canada Winter Games Team NT Female Hockey Selection Camp August 16-19, 2018
2019 Canada Winter Games Team NT Female Hckey Selectin Camp August 16-19, 2018 Strength and Cnditining Recmmendatins As discussed in the Call Fr Players letter, it is critical fr players t get their bdies
More informationWhat is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center
A cllabrative effrt f Children s Hspital f Pittsburgh f UPMC and The Pennsylvania Child Welfare Resurce Center What is Asthma? Jennifer E. Wlfrd, DO, MPH, FAAP Children s Hspital f Pittsburgh, Divisin
More informationPATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.
PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr
More informationThe Mental Capacity Act 2005; a short guide for the carers and relatives of those who may need support. Ian Burgess MCA Lead 13 February 2017
The Mental Capacity Act 2005; a shrt guide fr the carers and relatives f thse wh may need supprt Ian Burgess MCA Lead 13 February 2017 Agenda Overview f the MCA The 5 Principles and the legal definitin
More informationPatient Name: Address City State Zip Code. H. Phone W. Phone Cell Phone
Name yu prefer t g by: Address City State Zip Cde H. Phne W. Phne Cell Phne Email Address: Sex: M F Date f Birth Age Marital Status: M S D W Spuse s Name if Married: Scial Security # Referred by: Persn
More informationPROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS
PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS INTRODUCTION This ntice prvides an verview f the parental special educatin rights, smetimes called prcedural safeguards
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationInfluenza (Flu) Fact Sheet
Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder
More informationThis information shows what new challenges are likely to require prevention efforts moving forward.
Release f CDC s Healthcare-Assciated Infectins (HAI) Pint Prevalence Survey and Annual Natinal and State HAI Prgress Reprt Embarged until: Wednesday, March 26 th at 12 nn ET Key Messages Overall These
More informationMEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV
MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.
More informationReference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57
Reference: Patient A Brenda WXXXXX Date f Birth: 4/15/57 49 year ld white female patient presented n July 20, 2006 with chief cmplaint f stage 4 cancer, initially diagnsed in Octber, 2003 with Cervical
More information1/16/2019. Self Leadership Self Awareness and Leadership. Leader Traits and self-awareness Role management exercise Leadership Philosophy
Self Leadership Self Awareness and Leadership Finding yur vice (1 st step in Mdel the Way practice) Values in Actin SLPI reprt (January 28 th ) Leader Traits and self-awareness Rle management exercise
More information